Buy Vintor 4000mg - Erythropoietin Injection Online, Vintor 4000mg

Wishlist(0)

Vintor 4000mg - Erythropoietin Injection

Vintor 4000 IU is a recombinant human erythropoietin injection used to treat anemia in patients with chronic kidney disease, cancer undergoing chemotherapy, or HIV therapy. It helps stimulate red blood cell production, improving oxygen transport in the body.

Choose Quantity:

+ Add To Cart

Buy Now

Add to wishlist

Description Product Details

General Information:

Generic Name: Erythropoietin

Brand Name: Vintor

Packing: Pre-filled syringe or vial

Strength: 4000 IU

Manufacturer: Gennova Biopharmaceuticals

Form: Injectable solution

Category: Hematinic / Anti-anemic

Product Intro:

Vintor 4000 IU is a synthetic erythropoietin alpha formulation designed to effectively manage anemia. Manufactured by Gennova Biopharmaceuticals, it plays a key role in supporting patients with reduced red blood cell counts due to medical conditions or treatments like dialysis and chemotherapy.

Uses:

Anemia due to chronic kidney disease (CKD)
Anemia in cancer patients undergoing chemotherapy
Anemia associated with HIV therapy (especially with zidovudine)
Anemia in patients undergoing major surgery to reduce need for blood transfusions
Anemia following bone marrow or stem cell transplants
Anemia caused by myelodysplastic syndromes

Storage Instructions:

Store at 2°C to 8°C (refrigerated)
Do not freeze or expose to sunlight
Do not shake the syringe or vial
Keep away from children and pets

How it Works (Mechanism of Action):

Vintor mimics the natural hormone erythropoietin, which is normally produced by the kidneys. It stimulates the bone marrow to increase the production of red blood cells, helping alleviate symptoms of anemia like fatigue and weakness.

Side Effects:

Common Side Effects:

Fever
Headache
Dizziness
Nausea
Injection site redness or pain
High blood pressure

Severe Side Effects:

Blood clots
Stroke or heart attack (rare, in case of overcorrection)
Seizures
Pure red cell aplasia (PRCA)
Allergic reactions (anaphylaxis)

Dosage (Typical Recommended Dose):

4000 IU, typically given 2-3 times per week depending on patient’s condition and physician guidance
Dosage may be adjusted based on hemoglobin response
Regular monitoring is advised during treatment

Method of Administration:

Administered either subcutaneously (SC) or intravenously (IV)
Injection should be performed by a healthcare provider or trained caregiver
Rotate injection sites if SC
Let the solution reach room temperature before injection

Precautions:

Monitor blood pressure and hemoglobin regularly
Avoid in patients with uncontrolled hypertension
Use with caution in patients with seizure disorders or cardiovascular disease
Check for iron, folate, or vitamin B12 deficiencies and supplement as needed
Not advised for patients with a history of PRCA due to erythropoietin

Drug Interactions:

No major drug interactions, but inform your doctor about:
1. Chemotherapy agents
2. Antihypertensives
3. Iron supplements (can enhance effectiveness)

Allergies:

Contraindicated in patients allergic to erythropoietin or excipients in formulation
Watch for signs of allergy: hives, swelling, shortness of breath
Discontinue immediately if an allergic reaction occurs

Overdose Information:

Overdose may cause excessive erythrocytosis, leading to blood clots, stroke, or hypertension
Seek immediate medical attention
Management involves withholding the drug and symptomatic treatment

Missed Dose Instructions:

Take the missed dose as soon as remembered
If it's close to the next scheduled dose, skip the missed one
Never double the dose to catch up

Additional Notes:

Regular monitoring is critical for safe and effective use
Often combined with iron supplementation
Adjust dose gradually to avoid rapid hemoglobin increase
Should only be used under medical supervision